The short version
- Why people research itEyelash and brow density support (cosmetic).
- What the evidence isNo independent randomized trials — the human data is manufacturer-generated, reporting increased eyelash length and density with topical use.
- What to watchRed, swollen or crusted eyelids.
How Myristoyl Pentapeptide-17 works
Fatty-acid-modified peptide that stimulates keratin production in follicle keratinocytes — used for eyelash and brow growth.
Start with what cannot be written on this page, because it is the most important thing about the compound. There is no published amino-acid sequence for myristoyl pentapeptide-17.
What can still be computed, without the sequence. The myristoyl group is a 14-carbon acyl chain, C14H26O, adding 210.36 Da. The lightest pentapeptide that exists is five glycines, 303.27 Da, so the absolute floor for a myristoylated pentapeptide is 513.63 Da.
- Topical
On the goal map: Hair — follicle biology & the androgen problem (Skin, hair & aesthetics)
Where to get Myristoyl Pentapeptide-17
When a vetted partner does, the link and code go here.
Research on Myristoyl Pentapeptide-174 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No independent randomized trials — the human data is manufacturer-generated, reporting increased eyelash length and density with topical use. That is the weakest kind of clinical evidence there is: unblinded, unpublished in peer review, and produced by the party selling it. Worth reading as a starting point rather than a result.
Correlative data
Common in over-the-counter lash serums as the non-prostaglandin alternative to bimatoprost. Reported effect is markedly smaller — which is also why it does not carry bimatoprost's iris-pigmentation risk.
How the mechanism reads
A myristoylated peptide proposed to upregulate keratin genes in the hair follicle, increasing the structural protein available for the shaft.
MechanisticThat is a fundamentally different mechanism from bimatoprost, which extends the anagen growth phase. Building a thicker shaft and growing for longer are not the same lever, and the second one is stronger.
Mechanistic
Sources
- Fernandez-Gonzalez P, Trullas C, Granger C, Del Alcazar E, Sola J. Open clinical trial evaluating the efficacy of a novel eyelash growth enhancer with peptides and glycosaminoglycans. J Cosmet Dermatol 2024 · PMID 38572527
- Baiyasi M, Yousif J, Potts G. Eyelash serums: A comprehensive review. J Cosmet Dermatol 2024 · PMID 38475901
- Cohen JL. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth. Dermatol Surg 2010 · PMID 20384750
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000 · PMID 10839713
- Mortazavi SM, Moghimi HR. Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. Int J Cosmet Sci 2022 · PMID 35302659
- Choi YL, Park EK, Kim E, Na DH, Shin YH. Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS). Biomol Ther (Seoul) 2014 · PMID 25143811
- Resende DISP, Ferreira MS, Sousa-Lobo JM, Sousa E, Almeida IF. Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel) 2021 · PMID 34451799
- Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci 2009 · PMID 19570099
- Kluczyk A, Ludwiczak J, Modzel M, Kuczer M, Cebrat M, Biernat M, Bartosz-Bechowski H. Argireline: Needle-Free Botox as Analytical Challenge. Chem Biodivers 2021 · PMID 33482052
Myristoyl Pentapeptide-17 safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Eye disease, recent eye surgery or irritated eyes: it is applied beside the eye.
- Known allergy to myristoyl peptides or lash serum bases.
- Pregnancy, if you want to avoid any extra variable.
What’s expected
- Longer, thicker lashes or brows over weeks from keratin gene upregulation in follicle cells.
- Mild itch or redness at the lash line.
- Effect fades if use stops.
Watch for
- Red, swollen or crusted eyelids.
- Eye pain, blurred vision or light sensitivity.
- Darkening of the lid skin.
Labs that tell you it’s working
- Thyroid Antibodies (TPO + TgAb)
- TSH (Thyroid-Stimulating Hormone)
- Ferritin
- Zinc, Plasma
Myristoyl Pentapeptide-17 raises keratin production in follicle keratinocytes; hair-growth limiters like thyroid status, iron and zinc are what labs can show.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Myristoyl Pentapeptide-17 FAQ4 common questions
- Is Myristoyl Pentapeptide-17 approved for human use?
- No. Myristoyl Pentapeptide-17 is a research compound.
- What is Myristoyl Pentapeptide-17 researched for?
- Eyelash and brow density support (cosmetic).
- Which labs show whether it's doing anything?
- Thyroid Antibodies; TSH; Ferritin; Zinc, Plasma: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Myristoyl Pentapeptide-17: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



